Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.58), $0.04 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $30 million versus the consensus estimate of $22.04 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.